News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Melatonin inhibits FAK signaling to suppress PD-L1 expression and enhance chemosensitivity in triple-negative breast cancer
- Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence
- Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy
- Targeting growth hormone in cancer: future perspectives
- Tumour-Derived Human Growth Hormone As a Therapeutic Target in Oncology
- Melatonin induces apoptosis and cell cycle arrest in cervical cancer cells via inhibition of NF-κB pathway
- Molecular basis of melatonin protective effects in metastasis: A novel target of melatonin
- GH and IGF1 in cancer therapy resistance
- Empowering exhausted T cells of Glioblastoma patients by Neurotransmitters and Neuropeptides: decreasing immune checkpoint inhibitors, and increasing CD3zeta, proliferation and Glioblastoma arrest
- Integrative Use of Cannabidiol, Melatonin, and Oxygen-Ozone Therapy in Triple-Negative Breast Cancer with Lung and Mediastinal Metastases. A Case Report
- All-trans-retinoic acid and cancer
- A retrospective observational clinical study of triple negative breast cancer cases treated with Di Bella Method: A preliminary data
- Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
- Vitamin D modulates the basal secretion of inflammatory cytokines in breast cancer cells: An in-vitro study
- Evaluation of radio-protective effect of melatonin on whole body irradiation induced liver tissue damage
- Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer
- Melatonin as an anti-inflammatory agent in radiotherapy
- Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Bibliography
- How effective is chemo therapy?
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer